---
author: Harvey Guo
created: 2023-12-29 13:48
modified: 2023-12-29 13:48
aliases:
  - Non-Hodgkin lymphoma
  - NHL
share: true
---
# Epidemiology


---
# Etiology


---
# Pathophysiology


---
# Clinical features
## Indolent (low-grade)
- <span style="background:rgba(240, 200, 0, 0.2)">Follicular lymphoma</span>	
	- Most common low-grade lymphoma in adults
	- <span style="background:rgba(240, 200, 0, 0.2)">Slowly progressive and painless course with an alternating (waxing and waning) pattern of lymphadenopathy and splenomegaly</span>
	- Translocation t(14;18), which involves the heavy-chain Ig (chromosome 14) and Bcl-2 gene (chromosome 18) → overexpression of Bcl-2 → dysregulation of apoptosis (normally inhibited by Bcl-2)

---
# Diagnostics
## Chromosomal translocations

| Malignancy                   | Pathogenesis                                                                                                                                                                                                         |
|------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Acute promyelocytic leukemia | t(15;17) involving PML & RARA → PML-RARα oncoprotein → myeloid differentiation inhibited<br>RARα: nuclear receptor involved in myeloid differentiation<br>PML: fusion forms receptor with dominant negative activity |
| Burkitt lymphoma             | t(8;14) involving MYC & IGH → MYC overexpression → cell growth<br>MYC: transcription factor regulating cell growth<br>IGH: immunoglobulin heavy chain (high expression in B cells)                                   |
| Chronic myeloid leukemia     | t(9;22) involving ABL1 & BCR → BCR-ABL1 oncoprotein → cell proliferation<br>ABL1: nonreceptor tyrosine kinase<br>BCR: fusion leads to activation                                                                     |
| Follicular lymphoma          | t(14;18) involving IGH & BCL2 → BCL2 overexpression → apoptosis evasion<br>BCL2: antiapoptotic protein                                                                                                               |
| Mantle cell lymphoma         | t(11;14) involving CCND1 & IGH → cyclin D1 overexpression → cell cycle progression<br>Cyclin D1: regulates cell cycle progression                                                                                    |


---
# Treatment
## Specific regimens
- [[./Hairy cell leukemia|Hairy cell leukemia]]
	- Chemotherapy with <span style="background:rgba(240, 200, 0, 0.2)">cladribine or pentostatin</span>

---
